Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's ...

Yahoo Finance - 29 Mar 2024
Most readers would already know that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased by 9.6% over the past...

REGN (Regeneron Pharmaceuticals) Free Cash Flow

GuruFocus.com - 24 Apr 2024
REGN (Regeneron Pharmaceuticals) Free Cash Flow ...

REGN Stock Quote Price and Forecast

CNN - 16 Feb 2024
REGN Stock Quote Price and Forecast ...

Regeneron Pharmaceuticals (REGN) to Release Earnings on Thursday

MarketBeat - 25 Apr 2024
Regeneron Pharmaceuticals (REGN) to Release Earnings on Thursday ...

An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47% Undervalued

Yahoo Finance - 10 Apr 2024
An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47% Undervalued ...

REGN Stock Hits A Record High — Again — As It Tacks On New Wins

Investor's Business Daily - 12 Jan 2024
REGN Stock Hits A Record High — Again — As It Tacks On New Wins ...

Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea

Yahoo Finance - 12 Apr 2024
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea ...

Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its Financial Health?

Yahoo Finance - 30 Mar 2024
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its Financial Health? ...

Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment?

Yahoo Finance - 26 Mar 2024
Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment? ...

EXEL or REGN: Which Is the Better Value Stock Right Now?

Yahoo Finance - 09 Apr 2024
EXEL or REGN: Which Is the Better Value Stock Right Now? ...

Are Investors Undervaluing Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) By 42%?

Yahoo Finance - 07 Feb 2024
Are Investors Undervaluing Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) By 42%? ...

Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 42% Undervaluation?

Yahoo Finance - 09 Mar 2024
Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 42% Undervaluation? ...

Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen impressive returns of 146% over the past five ...

Yahoo Finance - 06 Apr 2024
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen impressive returns of 146% over the past five ... ...

Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA

Yahoo Finance - 26 Mar 2024
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA ...

Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?

Yahoo Finance - 03 Jan 2024
Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains? ...

EXEL vs. REGN: Which Stock Is the Better Value Option?

Yahoo Finance - 06 Mar 2024
EXEL vs. REGN: Which Stock Is the Better Value Option? ...

Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their impressive 139% return over the ...

Yahoo Finance - 04 Mar 2024
Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their impressive 139% return over the ... ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2023 Earnings Call Transcript

Yahoo Finance - 03 Feb 2024
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2023 Earnings Call Transcript ...

Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following Fundamentals?

Yahoo Finance - 29 Feb 2024
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following Fundamentals? ...

Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates

Yahoo Finance - 28 Mar 2024
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates ...

REGN